High Purity 99% Oseltamivir Powder CAS 196618 -13-0

China High Purity 99% Oseltamivir Powder CAS 196618-13-0, Find details about China 196618-13-0, CAS 196618-13-0 from High Purity 99% Oseltamivir Powder CAS 196618-13-0

Basic Info.

Model NO.

196618-13-0

Storage Condition

Store at Rt

Trademark

FOUSI

Transport Package

Aluminium Foil Bag

Specification

Origin

China

Model NO.

196618-13-0

Storage Condition

Store at Rt

Trademark

FOUSI

Transport Package

Aluminium Foil Bag

Specification

Origin

China

Product Desciption

High Purity 99% Oseltamivir Powder CAS 196618-13-0

Product Name	Oseltamivir
CAS NO	196618-13-0
Molecular Weight	312.405
Density	1.2±0.1 g/cm3
Boiling Point	445.4±55.0 °C at 760 mmHg
Molecular Formula	C₁₆H₂₈N₂O₄
Melting Point	N/A
Flash Point	223.2±31.5 °C

High Purity 99% Oseltamivir Powder CAS 196618-13-0

OSELTAMIVIR Chemical Properties

Melting point	107-108 °C
Boiling point	473.3±45.0 °C(Predicted)
density	1.08±0.1 g/cm3(Predicted)
storage temp.	Keep in dark place,Sealed in dry,2-8°C
pka	7.7 (25°); 6.6 (70°)
CAS DataBase Reference	196618-13-0
EPA Substance Registry System	1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R,4R,5S)- (196618-13-0)

Oseltamivir is a prodrug of its active metabolite, and its active metabolite (oseltamivir carboxylate) is a selective influenza virus neuraminidase inhibitor. Neuraminidase is a glycoprotein on the surface of the virus whose activity is essential for the release of newly formed viral particles from infected cells and the further spread of infectious viruses in the human body.

The active metabolite of oseltamivir phosphate inhibits the neuraminidase activity of influenza A and B viruses. The half-inhibitory concentration of viral neuraminidase activity in vitro is as low as the nanogram level. It has been observed in vitro that active metabolites inhibit the growth of influenza virus, and its inhibition of influenza virus replication and pathogenicity is also observed in vivo. This product reduces the spread of influenza A or B by inhibiting the release of the virus from infected cells.

Studies of naturally acquired and laboratory influenza have shown that the use of oseltamivir phosphate does not affect the body's normal humoral immune response to infection. The antibody response to the inactivated vaccine was not affected by treatment with oseltamivir phosphate.

High Purity 99% Oseltamivir Powder CAS 196618-13-0